CRISPR Therapeutics AG
(NASDAQ : CRSP)

( )
CRSP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -0.97%141.610.0%$4046.77m
BIIBBiogen, Inc. 0.00%246.921.7%$672.25m
NVAXNovavax, Inc. -0.62%124.7092.9%$659.46m
BNTXBioNTech SE -1.75%118.970.0%$639.41m
AMGNAmgen, Inc. 0.00%226.561.3%$596.68m
GILDGilead Sciences, Inc. 0.00%61.131.0%$518.23m
VRTXVertex Pharmaceuticals, Inc. 0.00%226.701.9%$491.83m
REGNRegeneron Pharmaceuticals, Inc. 0.00%505.132.7%$477.29m
ILMNIllumina, Inc. 0.00%340.823.5%$413.19m
APVOAptevo Therapeutics, Inc. 0.00%47.7618.3%$252.82m
EXASEXACT Sciences Corp. 0.00%124.4119.6%$178.29m
SGENSeagen Inc. 0.00%177.045.8%$174.97m
ALXNAlexion Pharmaceuticals, Inc. 0.00%122.752.0%$145.85m
BGNEBeiGene Ltd. 0.00%227.001.4%$133.74m
SRNESorrento Therapeutics, Inc. 1.03%7.851.4%$133.22m

Company Profile

CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan and Craig Mellow in 2014 and is headquartered in Zug, Switzerland.